Alexandria Real Estate Equities
ARE
#2319
Rank
โ‚น706.12 B
Marketcap
โ‚น4,086
Share price
-2.38%
Change (1 day)
-52.10%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Revenue for Alexandria Real Estate Equities (ARE)

Revenue in 2025 (TTM): โ‚น257.56 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current revenue (TTM ) is โ‚น267.67 Billion. In 2024 the company made a revenue of โ‚น261.62 Billion an increase over the revenue in the year 2023 that were of โ‚น236.63 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alexandria Real Estate Equities from 1997 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น257.56 B-1.55%
2024 โ‚น261.62 B10.56%
2023 โ‚น236.63 B11.01%
2022 โ‚น213.16 B35.85%
2021 โ‚น156.91 B14.24%
2020 โ‚น137.36 B26.99%
2019 โ‚น108.16 B17.66%
2018 โ‚น91.93 B28.23%
2017 โ‚น71.69 B17.5%
2016 โ‚น61.01 B12.03%
2015 โ‚น54.46 B19.29%
2014 โ‚น45.65 B19.18%
2013 โ‚น38.30 B16.48%
2012 โ‚น32.88 B24.57%
2011 โ‚น26.40 B28.31%
2010 โ‚น20.57 B13.9%
2009 โ‚น18.06 B0.52%
2008 โ‚น17.97 B45.17%
2007 โ‚น12.37 B14.37%
2006 โ‚น10.82 B25.73%
2005 โ‚น8.60 B28.66%
2004 โ‚น6.69 B10.64%
2003 โ‚น6.04 B7.66%
2002 โ‚น5.61 B18.01%
2001 โ‚น4.76 B25.75%
2000 โ‚น3.78 B30.96%
1999 โ‚น2.89 B44.66%
1998 โ‚น1.99 B82.92%
1997 โ‚น1.09 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚น5.640 T 2,007.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.612 T 876.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น5.338 T 1,894.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น385.21 B 43.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.315 T 1,512.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.231 T 1,107.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น288.38 B 7.74%๐Ÿ‡บ๐Ÿ‡ธ USA